Tx360® – INTENDED FOR USE
One and only device of its kind in the world, Tx360® is a revolution in medication delivery.
The Tx360® Nasal Applicator is a specially designed medical device intended for use in adults to deliver small amounts of fluid (= 0.6cc, luer lock) selected by a healthcare professional to the nasal pathway, including the area of the inferior turbinate, superior turbinate, sphenopalatine foramen, etc. It is intended for use on adult patients with intact nasal mucosa. The device allows easy, safe and instant access to the inner most hidden areas of the nasal pathway.
5 based on Subjects receiving bupivacaine reported significantly improved levels of Patient Global Impression of Change (PGIC) scores compared to those treating with saline, (p < .001) at both 30 minutes and 24 hours post treatment. Total acute medication usage was similar between the two groups. However, the average usage of opioids per subject during the treatment phase was lower in the bupivacaine group compared to the saline group (8.33 vs. 45.7). There was no difference in non-serious and serious adverse events between groups. reviews $65.00 usd New